EUR 0.43
(4.88%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | 4.76 Million | 3.74 Million | 1.56 Million | 2.94 Million | - |
Net Income | -4.03 Million | -4.94 Million | -3.35 Million | 203.1 Thousand | 210.9 Thousand | 123.25 Thousand |
Depreciation & Amortization | - | 2.38 Million | 1.87 Million | 1.24 Million | 1.02 Million | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | 111.9 Thousand | 1.71 Million | - |
Other non-cash items | 4.03 Million | 4.94 Million | 3.35 Million | 700.00 | 300.00 | -123.25 Thousand |
Investing Cash Flow | - | - | - | -2.91 Million | -1.94 Million | - |
Investments in PPE | - | - | - | -2.91 Million | -1.94 Million | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | 600.00 | - |
Financing Cash Flow | - | - | - | 637 Thousand | 162.9 Thousand | - |
Debt repayment | - | - | - | -166.3 Thousand | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | 803.3 Thousand | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | 5.29 Million | 517.72 Thousand | 1.23 Million | 71.1 Thousand | - |
Cash at end of period | - | 1.72 Million | 5.29 Million | 517.6 Thousand | 1.23 Million | - |
Capital Expenditure | - | - | - | -2.91 Million | -1.94 Million | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | -3.56 Million | 4.77 Million | -715.2 Thousand | 1.16 Million | - |
Free Cash Flow | - | 4.76 Million | 3.74 Million | -1.35 Million | 998.2 Thousand | - |
Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -4.03 Million | -761.31 Thousand | -761.31 Thousand | -1.25 Million | -1.25 Million | -4.94 Million |
Depreciation & Amortization | - | - | - | 1.13 Million | - | 2.38 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | 4.03 Million | 761.31 Thousand | 761.31 Thousand | 1.25 Million | 1.25 Million | 4.94 Million |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | - | - | 1.72 Million | - | 5.29 Million |
Cash at end of period | - | - | - | 2.62 Million | - | 1.72 Million |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | 903.61 Thousand | - | -3.56 Million |
Free Cash Flow | - | - | - | 2.27 Million | - | 4.76 Million |
4187
M7U
2371
2462
SB1
GEVO